Form 8-K - Current report:
SEC Accession No. 0001193125-26-007077
Filing Date
2026-01-08
Accepted
2026-01-08 09:00:32
Documents
42
Period of Report
2026-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrv-20260108.htm   iXBRL 8-K 47486
2 EX-99.1 acrv-ex99_1.htm EX-99.1 35400
3 GRAPHIC acrv-ex99_1s1.jpg GRAPHIC 255862
4 GRAPHIC acrv-ex99_1s2.jpg GRAPHIC 697310
5 GRAPHIC acrv-ex99_1s3.jpg GRAPHIC 241232
6 GRAPHIC acrv-ex99_1s4.jpg GRAPHIC 285479
7 GRAPHIC acrv-ex99_1s5.jpg GRAPHIC 480492
8 GRAPHIC acrv-ex99_1s6.jpg GRAPHIC 475690
9 GRAPHIC acrv-ex99_1s7.jpg GRAPHIC 604790
10 GRAPHIC acrv-ex99_1s8.jpg GRAPHIC 452424
11 GRAPHIC acrv-ex99_1s9.jpg GRAPHIC 249550
12 GRAPHIC acrv-ex99_1s10.jpg GRAPHIC 332717
13 GRAPHIC acrv-ex99_1s11.jpg GRAPHIC 435333
14 GRAPHIC acrv-ex99_1s12.jpg GRAPHIC 349109
15 GRAPHIC acrv-ex99_1s13.jpg GRAPHIC 409458
16 GRAPHIC acrv-ex99_1s14.jpg GRAPHIC 406364
17 GRAPHIC acrv-ex99_1s15.jpg GRAPHIC 503423
18 GRAPHIC acrv-ex99_1s16.jpg GRAPHIC 353924
19 GRAPHIC acrv-ex99_1s17.jpg GRAPHIC 326162
20 GRAPHIC acrv-ex99_1s18.jpg GRAPHIC 395883
21 GRAPHIC acrv-ex99_1s19.jpg GRAPHIC 319202
22 GRAPHIC acrv-ex99_1s20.jpg GRAPHIC 389106
23 GRAPHIC acrv-ex99_1s21.jpg GRAPHIC 407480
24 GRAPHIC acrv-ex99_1s22.jpg GRAPHIC 397819
25 GRAPHIC acrv-ex99_1s23.jpg GRAPHIC 355805
26 GRAPHIC acrv-ex99_1s24.jpg GRAPHIC 493133
27 GRAPHIC acrv-ex99_1s25.jpg GRAPHIC 471740
28 GRAPHIC acrv-ex99_1s26.jpg GRAPHIC 343453
29 GRAPHIC acrv-ex99_1s27.jpg GRAPHIC 399133
30 GRAPHIC acrv-ex99_1s28.jpg GRAPHIC 487559
31 GRAPHIC acrv-ex99_1s29.jpg GRAPHIC 449883
32 GRAPHIC acrv-ex99_1s30.jpg GRAPHIC 234043
33 GRAPHIC acrv-ex99_1s31.jpg GRAPHIC 549195
  Complete submission text file 0001193125-26-007077.txt   17491516

Data Files

Seq Description Document Type Size
34 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acrv-20260108.xsd EX-101.SCH 25798
44 EXTRACTED XBRL INSTANCE DOCUMENT acrv-20260108_htm.xml XML 4888
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41551 | Film No.: 26517609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)